cefixime has been researched along with Lung Diseases, Obstructive in 2 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lieberman, D | 1 |
| Schlaeffer, F | 1 |
2 other studies available for cefixime and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bac | 1995 |
[Direct costs to primary care of chronic bronchitis. Analysis of a prospective study].
Topics: Aged; Anti-Bacterial Agents; Bronchitis; Cefixime; Chronic Disease; Cohort Studies; Direct Service C | 2001 |